Sandip Kapadia
CIK 1677141 · CHIEF FINANCIAL OFFICER · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$877.1K
Companies
3
Total Filings
61
Lifetime Open-Market Net
-$4.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 0 | $4.57 | $0 | $84.0K | 9 | 2026-05-21 |
| HRMY | CHIEF FINANCIAL OFFICER | 24,521 | $35.77 | $877.1K | -$3.89M | 17 | 2026-01-28 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | CFO and Treasurer | 40,964 | $19.00 | $778.3K | -$306.3K | 19 | 2021-01-26 |
Recent Filings · Page 3 of 7
61 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-15 | HRMY | Notice (144) | −21,573 | -$787.6K | EDGAR |
| 2025-05-30 | PASG | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | HRMY | Sell (S) | −6,987 | -$227.4K | EDGAR |
| 2025-04-01 | HRMY | Notice (144) | −6,986 | -$231.9K | EDGAR |
| 2025-04-01 | HRMY | Mixed | +6,986 | -$266.0K | EDGAR |
| 2025-01-28 | HRMY | Mixed | — | -$145.0K | EDGAR |
| 2025-01-27 | HRMY | Notice (144) | −1,775 | -$67.5K | EDGAR |
| 2025-01-23 | HRMY | Mixed | — | -$278.8K | EDGAR |
| 2025-01-21 | HRMY | Notice (144) | −25,000 | -$976.2K | EDGAR |
| 2024-10-02 | HRMY | Mixed | +27,948 | -$1.28M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.